A rational approach to re-engineer cytochrome P4502B1 regioselectivity based on the crystal structure of cytochrome P4502C5

被引:47
作者
Kumar, S [1 ]
Scott, EE [1 ]
Liu, H [1 ]
Halpert, JR [1 ]
机构
[1] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
关键词
D O I
10.1074/jbc.M212515200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The regioselectivity for progesterone hydroxylation by cytochrome P450 2B1 was re-engineered based on the x-ray crystal structure of cytochrome P450 2C5. 2B1 is a high K-m progesterone 16alpha-hydroxylase, whereas 2C5 is a low K-m progesterone 21-hydroxylase. Initially, nine individual 2B1 active-site residues were changed to the corresponding 2C5 residues, and the mutants were purified from an Escherichia coli expression system and assayed for progesterone hydroxylation. At 150 muM progesterone, I114A, F297G, and V363L showed 5-15% of the 21-hydroxylase activity of 2C5, whereas F206V showed high activity for an unknown product and a 13-fold decrease in K-m. Therefore, a quadruple mutant, I114A/F206V/F297G/V363L (Q), was constructed that showed 60% of 2C5 progesterone 21-hydroxylase activity and 57% regioselectivity. Based on their 2C5-like testosterone hydroxylation profiles, S294D and I477F alone and in combination were added to the quadruple mutant. All three mutants showed enhanced regioselectivity (70%) for progesterone 21-hydroxylation, whereas only Q/I477F had a higher k(cat). Finally, the remaining three single mutants, V103I, V367L, and G478V, were added to Q/I477F and Q/S294D/I477F, yielding seven additional multiple mutants. Among these, Q/V103I/S294D/I477F showed the highest k(cat) (3-fold higher than that of 2C5) and 80% regioselectivity for progesterone 21-hydroxylation. Docking of progesterone into a three-dimensional model of this mutant indicated that 21-hydroxylation is favored. In conclusion, a systematic approach to convert P450 regioselectivity across subfamilies suggests that active-site residues are mainly responsible for regioselectivity differences between 2B1 and 2C5 and validates the reliability of 2B1 models based on the crystal structure of 2C5.
引用
收藏
页码:17178 / 17184
页数:7
相关论文
共 47 条
[1]   Competitive CYP2C9 inhibitors:: Enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis [J].
Afzelius, L ;
Zamora, I ;
Ridderström, M ;
Andersson, TB ;
Karlén, A ;
Masimirembwa, CM .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :909-919
[3]   Protein engineering of oxygenases for biocatalysis [J].
Cirino, PC ;
Arnold, FH .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (02) :130-135
[4]   Engineering microsomal cytochrome P4502C5 to be a soluble, monomeric enzyme - Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding [J].
Cosme, J ;
Johnson, EF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2545-2553
[5]  
Domanski TL, 1999, J PHARMACOL EXP THER, V290, P1141
[6]   Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis [J].
Domanski, TL ;
Halpert, JR .
CURRENT DRUG METABOLISM, 2001, 2 (02) :117-137
[7]   The role of cytochrome 2B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins [J].
Domanski, TL ;
He, YQ ;
Scott, EE ;
Wang, QM ;
Halpert, JR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 394 (01) :21-28
[8]   Directed enzyme evolution [J].
Farinas, ET ;
Bulter, T ;
Arnold, FH .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (06) :545-551
[9]   BIOCHEMISTRY AND MOLECULAR-BIOLOGY OF THE HUMAN CYP2C SUBFAMILY [J].
GOLDSTEIN, JA ;
DEMORAIS, SMF .
PHARMACOGENETICS, 1994, 4 (06) :285-299
[10]  
GOTOH O, 1992, J BIOL CHEM, V267, P83